Interplay between Host and Pathogen: Effects of Infection and Immune Responses

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Pathogens-host Immune Interface".

Deadline for manuscript submissions: 30 June 2024 | Viewed by 7830

Special Issue Editors


E-Mail Website
Guest Editor
Department of Health Sciences, School of Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy
Interests: antibiotic resistance; infectious disease; pathogenic molecular mechanisms; bacteriology; virology; antiviral resistance
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Health Sciences, School of Medicine, University of Catanzaro “Magna Græcia”, 88100 Catanzaro, Italy
Interests: epidemiology; advanced biostatistics; statistical modelling; neuroradiology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The complex network of interactions between a host and pathogen determines the outcome of infection. Following invasion by a pathogen, the host cannot always neutralize the microorganism, which may survive as a persistent infection. Such a condition is crucial both environmentally and evolutionarily because it can affect infection prevalence, transmission and virulence evolution. However, the factors causing variation in infection outcomes, and the balance between clearance and virulence are not well understood. Within the host a number of processes may play a role in pathogen persistent infection or clearance. These include different degrees of host selective pressures such as: molecular, immunological, epidemiological, host heterogeneity, spatial structure, population bottlenecks and other stochastic processes. On the other hand, the variability in virulence of microorganisms impacts on pathogenicity and clearance rates. Thus, the variance in infection outcomes is thereby determined by how microbe virulence—and its components—relate to multiple host defence facets.

We are pleased to invite you, with the presentation of this special issue, to recent advances in the decoding of mechanisms of persistent infection and the role of host immune response on clinical outcomes, as well as investigation of the interactions between invading pathogen virulence factors and the immune system of the host organism tasked with counteracting them.

This Special Issue aims to point out new insights into the host-pathogen interplay. In particular, it should provide valuable findings in the virulence and immunological mechanisms underlying such interactions, and their role in host defence. In this Special Issue, original research articles and reviews are welcome. Adding new information on these subjects may lead to a better understanding of the pathogenesis of different diseases and aid in the design of new therapeutic and prophylactic strategies.

We look forward to receiving your contributions.

Dr. Grazia Pavia
Dr. Gianfranco Di Gennaro
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • host immune response
  • virulence determinants
  • pathogen-host interaction
  • immune responses
  • therapeutic strategies
  • vaccines

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

12 pages, 1245 KiB  
Article
Evaluation of IL-35, as a Possible Biomarker for Follow-Up after Therapy, in Chronic Human Schistosoma Infection
by Nadia Marascio, Maria Teresa Loria, Grazia Pavia, Cinzia Peronace, Neill James Adams, Morena Campolo, Francesca Divenuto, Angelo Giuseppe Lamberti, Aida Giancotti, Giorgio Settimo Barreca, Maria Mazzitelli, Enrico Maria Trecarichi, Carlo Torti, Francesca Perandin, Zeno Bisoffi, Angela Quirino and Giovanni Matera
Vaccines 2023, 11(5), 995; https://doi.org/10.3390/vaccines11050995 - 17 May 2023
Viewed by 5087
Abstract
The host response to helminth infections is characterized by systemic and tissue-related immune responses that play a crucial role in pathological diseases. Recently, experimental studies have highlighted the role of regulatory T (Tregs) and B (Bregs) cells with secreted cytokines as important markers [...] Read more.
The host response to helminth infections is characterized by systemic and tissue-related immune responses that play a crucial role in pathological diseases. Recently, experimental studies have highlighted the role of regulatory T (Tregs) and B (Bregs) cells with secreted cytokines as important markers in anti-schistosomiasis immunity. We investigated the serical levels of five cytokines (TNFα, IFN-γ, IL-4, IL-10 and IL-35) in pre- and post-treatment samples from chronic Schistosoma infected patients to identify potential serological markers during follow-up therapy. Interestingly, we highlighted an increased serum level of IL-35 in the pre-therapy samples (median 439 pg/mL for Schistosoma haematobium and 100.5 pg/mL for Schistsoma mansoni infected patients) compared to a control group (median 62 pg/mL and 58 pg/mL, respectively, p ≤ 0.05), and a significantly lower concentration in post-therapy samples (181 pg/mL for S. haematobium and 49.5 pg/mL for S. mansoni infected patients, p ≤ 0.05). The present study suggests the possible role of IL-35 as a novel serological biomarker in the evaluation of Schistosoma therapy follow-up. Full article
Show Figures

Figure 1

Review

Jump to: Research

22 pages, 912 KiB  
Review
Studying T Cell Responses to Hepatotropic Viruses in the Liver Microenvironment
by Jarrett Lopez-Scarim, Shashank Manohar Nambiar and Eva Billerbeck
Vaccines 2023, 11(3), 681; https://doi.org/10.3390/vaccines11030681 - 17 Mar 2023
Cited by 1 | Viewed by 2079
Abstract
T cells play an important role in the clearance of hepatotropic viruses but may also cause liver injury and contribute to disease progression in chronic hepatitis B and C virus infections which affect millions of people worldwide. The liver provides a unique microenvironment [...] Read more.
T cells play an important role in the clearance of hepatotropic viruses but may also cause liver injury and contribute to disease progression in chronic hepatitis B and C virus infections which affect millions of people worldwide. The liver provides a unique microenvironment of immunological tolerance and hepatic immune regulation can modulate the functional properties of T cell subsets and influence the outcome of a virus infection. Extensive research over the last years has advanced our understanding of hepatic conventional CD4+ and CD8+ T cells and unconventional T cell subsets and their functions in the liver environment during acute and chronic viral infections. The recent development of new small animal models and technological advances should further increase our knowledge of hepatic immunological mechanisms. Here we provide an overview of the existing models to study hepatic T cells and review the current knowledge about the distinct roles of heterogeneous T cell populations during acute and chronic viral hepatitis. Full article
Show Figures

Figure 1

Back to TopTop